NDC11 00409162602
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00409-1626-02 | 00409-1626 |
| 00409-1626-2 | 00409-1626 |
| 0409-1626-02 | 0409-1626 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Butorphanol Tartrate | BUTORPHANOL TARTRATE | Hospira, Inc. | 9822ca3f-aee2-46e5-8a96-495400e65d10 | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | 0409-1626-02 0409-1626 00409162602 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.